|

Pafolacianine Sodium Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Cytalux

Pipeline

Phase 3: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Metastatic Childhood Malignant Solid Neoplasm1
  • Malignant Neck Neoplasm1
  • Malignant Abdominal Neoplasm1
  • Childhood Malignant Thoracic Neoplasm1
  • Childhood Malignant Solid Neoplasm1

Rochester, Minnesota1 trial

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Mayo Clinic in Rochester

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.